课题基金 / 基金详情

项目摘要

项目成果

MICHAEL OLIVIER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The metabolic syndrome is a common disorder posing a significant major risk for coronary heart disease and early mortality in the Western hemisphere. Central to its cardiovascular complications is the association of the syndrome with the specific abnormalities in plasma lipid and lipoprotein profiles including increased plasma triglycerides, decreased HDL cholesterol, and predominance of dense lipoprotein particles. In search for the genetic etiology of this lipid disorder, we identified a quantitative trait locus (QTL) on human chromosome 7q36 strongly linked to variation in plasma lipid levels. We hypothesize that this QTL contains genetic variants that contribute to alterations in biologic pathways underlying the genesis of the lipid disorder. To test for this hypothesis, we propose a comprehensive approach utilizing established resources and expertise to identify the functional sequence variants within this QTL. Specifically, we will 1.) identify single nucleotide polymorphisms (SNPs) and their haplotype and linkage disequilibrium structure across the entire QTL region; 2.) Analyze association of informative SNPs with plasma triglyceride levels, LDL levels, and lipoprotein density fractions using variance component linkage/disequilibrium analyses; and 3.) Identify potentially functional sequence variants in associated genes or genomic regions using Bayesian quantitative trait nucleotide analysis. This comprehensive application of newly available genomic technologies, novel statistical approaches, the DNA and phenotypic information available, and the consortium of expertise assembled behind this project will ensure the successful elucidation of the genetic etiology of this lipid disorder and consequently the development of effective means for prevention and/or treatment of cardiovascular complications of the metabolic syndrome.
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
Obesity and its therapy: from genes to community action.
肥胖及其治疗:从基因到社区行动。
DOI: 10.1016/j.pcl.2006.05.011
发表时间: 2006
期刊: Pediatric clinics of North America
影响因子: 2.6
作者: [Skelton,JosephA, DeMattia,Laure, Miller,Lawrence, Olivier,Michael]
通讯作者: Olivier,Michael
Putting the Invader assay to work: laboratory application and data management.
让 Invader 检测发挥作用:实验室应用和数据管理。
DOI: 10.1007/978-1-60327-411-1_22
发表时间: 2009
期刊: Methods in molecular biology (Clifton, N.J.)
影响因子: --
作者: [Zhang,Yi, Smith,Edward, Olivier,Michael]
通讯作者: Olivier,Michael
DOI: 10.1186/1471-2164-14-468
发表时间: 2013-07-10
期刊: BMC genomics
影响因子: 4.4
作者: [Indap AR, Cole R, Runge CL, Marth GT, Olivier M]
通讯作者: Olivier M
Serotonin (5-HT) receptor 5A sequence variants affect human plasma triglyceride levels.
血清素 (5-HT) 受体 5A 序列变异会影响人血浆甘油三酯水平。
DOI: 10.1152/physiolgenomics.00038.2010
发表时间: 2010
期刊: Physiological genomics
影响因子: 4.6
作者: [Zhang,Y, Smith,EM, Baye,TM, Eckert,JV, Abraham,LJ, Moses,EK, Kissebah,AH, Martin,LJ, Olivier,M]
通讯作者: Olivier,M
7
    North Carolina Diabetes Research Center
    Admin-Core
    Admin-Core
    Admin-Core
    海外基金